{"id":987505307,"date":"2024-07-23T07:36:05","date_gmt":"2024-07-23T07:36:05","guid":{"rendered":"https:\/\/hollandcapital.nl\/?p=987505307"},"modified":"2024-07-23T07:45:58","modified_gmt":"2024-07-23T07:45:58","slug":"holland-capital-announces-successful-exit-of-defibrion-to-ik-partners","status":"publish","type":"post","link":"https:\/\/hollandcapital.nl\/en\/holland-capital-announces-successful-exit-of-defibrion-to-ik-partners\/","title":{"rendered":"Holland Capital Announces Successful Exit of Defibrion to IK Partners"},"content":{"rendered":"\n[et_pb_section fb_built=”1″ _builder_version=”4.24.2″ _module_preset=”default” background_color=”#213564″ background_enable_image=”off” background_position=”top_center” background_vertical_offset=”38%” background_blend=”soft-light” height=”30vh” custom_padding=”0vh||8vh||false|false” global_colors_info=”{}”][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.18.1″ _module_preset=”default” custom_padding=”100px||100px||true|” global_colors_info=”{}”][et_pb_row _builder_version=”4.20.4″ _module_preset=”default” custom_margin=”|auto|15px|auto||” custom_padding=”0px|||||” locked=”off” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.20.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.25.1″ _module_preset=”default” text_font=”|800|||||||” text_text_color=”#243B66″ text_font_size=”35px” text_line_height=”1.2em” custom_margin=”||12px|||” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]

Holland Capital Announces Successful Exit of Defibrion to IK Partners<\/strong><\/p>[\/et_pb_text][et_pb_divider show_divider=”off” _builder_version=”4.20.4″ _module_preset=”default” width=”15%” custom_margin=”10px||||false|false” border_width_top=”3px” border_color_top=”#B68013″ border_color_bottom=”#B68013″ global_colors_info=”{}”][\/et_pb_divider][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.18.1″ _module_preset=”default” custom_padding=”0px||27px|||” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.18.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.25.1″ _module_preset=”default” header_font=”|800|||||||” header_text_color=”#283583″ header_2_font=”|800|||||||” header_2_text_color=”#283583″ header_2_font_size=”20px” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]

\n
\n
\n

Amsterdam\/Groningen, 23 July 2024 \u2013 Holland Capital is proud to announce that IK Partners (IK) has signed an agreement to acquire our portfolio company, Defibrion. Since 2019, Defibrion’s management team has successfully collaborated with Holland Capital. The shares of Defibrion are being sold to IK and the company\u2019s management team. IK is a leading European private equity firm focused on investments in\u00a0 the Benelux, DACH, France, Nordics and the UK.<\/strong><\/p>\n

Defibrion: A Leading Provider in AED Distribution and Safety Products<\/strong><\/p>\n

\u00a0<\/strong>Founded in 2008 by the current CEO Joshua Valkenier and based in Groningen, Defibrion is a market leader in the distribution of automated external defibrillators (AEDs) and related safety products. The company offers a wide range of products and services aimed at enhancing workplace safety. With over 6,400 customers worldwide, Defibrion serves as a one-stop-shop for emergency response needs. Its customer base, which includes more than 900 resellers in Europe and North America, comprises various end users such as offices, sports clubs, and government institutions.<\/p>\n

\u00a0Strategic Growth and Expansion<\/strong><\/p>\n

Since 2019, Holland Capital has been involved with Defibrion as a shareholder. They actively supported the management in professionalizing the organization and the strategic development of the company. Through a successful buy-and-build strategy and a focus on geographical expansion in Western Europe, Defibrion has been able to grow successfully.<\/p>\n

\u00a0Defibrion is now on the brink of a new phase in its development, which will be supported by IK. In this new phase, Defibrion will further scale up its existing operations, broaden its offerings, and expand into new markets. The strategic plan also includes exploring further buy-and-build opportunities to promote consolidation in the fragmented market of AEDs and related safety products.<\/p>\n

\u00a0Joshua Valkenier, founder and CEO of Defibrion, said: “When Holland Capital joined Defibrion as a shareholder in 2019, we had the ambition to internationalize, professionalize, and further expand our organization. I am pleased that we have achieved this and am grateful to Holland Capital for the pleasant and successful collaboration.<\/em>\u201d<\/p>\n

\u00a0Ewout Prins, managing partner of Holland Capital, commented: “The collaboration with Joshua Valkenier and the Defibrion team was both successful and enjoyable. When we joined, we were convinced that the AED market offered interesting growth opportunities, and Defibrion has demonstrated this. Their dedication and vision have played a crucial role in achieving this growth. We are proud to have contributed to the successful growth of Defibrion and its life-saving products. We wish the team much success in this next phase of growth.\u201d<\/em><\/p>\n

About Holland Capital<\/h2>\n

Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and strives for an open, sustainable, and professional relationship with the management teams of the companies they invest in, with the common goal of realizing growth. Holland Capital has offices in Amsterdam and D\u00fcsseldorf. With specialized sector teams, it focuses on the Healthcare, Technology, and Agrifood-Tech sectors. They understand the dynamics and opportunities, and have an extensive network in these sectors.<\/p>\n<\/div>\n<\/div>\n<\/div>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.18.1″ _module_preset=”default” background_color=”#EFEFEF” background_image=”https:\/\/hollandcapital.nl\/wp-content\/uploads\/2022\/11\/Molen_wit.png” background_blend=”soft-light” custom_padding=”100px||50px||false|” box_shadow_style=”preset6″ global_colors_info=”{}”][et_pb_row _builder_version=”4.18.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.18.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_blog fullwidth=”off” posts_number=”6″ include_categories=”31,97″ show_author=”off” show_categories=”off” show_excerpt=”off” _builder_version=”4.20.4″ _module_preset=”default” header_font=”|800|||||||” header_text_color=”#252E82″ body_text_color=”#000000″ meta_text_color=”#B68013″ pagination_text_color=”#B68013″ custom_css_title=”height: 100px;” border_radii=”on|5px|5px|5px|5px” border_width_all=”0px” box_shadow_style=”preset1″ global_colors_info=”{}” header_text_color__hover_enabled=”on|hover” header_text_color__hover=”#252E82″][\/et_pb_blog][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.24.2″ _module_preset=”default” background_color=”#213564″ custom_margin=”||||false|false” custom_padding=”60px||29px||false|false” saved_tabs=”all” global_colors_info=”{}”][et_pb_row column_structure=”1_5,1_5,1_5,1_5,1_5″ make_equal=”on” _builder_version=”4.18.1″ _module_preset=”default” custom_margin=”|auto|6px|auto||” custom_padding=”0px||0px|||” global_colors_info=”{}”][et_pb_column type=”1_5″ _builder_version=”4.18.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/hollandcapital.nl\/wp-content\/uploads\/2022\/11\/Holland-capital-logo-wit.png” title_text=”Holland capital logo-wit” _builder_version=”4.18.1″ _module_preset=”default” transform_translate_linked=”off” width=”91%” custom_margin=”||||false|false” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.18.1″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.18.1″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.18.1″ _module_preset=”default” custom_css_main_element=”margin:auto;” global_colors_info=”{}”][\/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.18.1″ _module_preset=”default” custom_css_main_element=”margin:auto;” global_colors_info=”{}”][et_pb_social_media_follow use_icon_font_size=”on” _builder_version=”4.18.1″ _module_preset=”default” custom_button=”on” button_text_size=”16px” button_text_color=”#283583″ button_bg_color=”#FFFFFF” button_border_color=”#FFFFFF” button_font=”|600|||||||” button_custom_margin=”||||false|false” button_custom_padding=”||||false|false” text_orientation=”left” background_layout=”dark” custom_margin=”||7px||false|false” global_colors_info=”{}”][et_pb_social_media_follow_network social_network=”linkedin” url=”https:\/\/www.linkedin.com\/company\/hollandcapital\/” icon_color=”#283583″ _builder_version=”4.18.1″ _module_preset=”default” background_color=”#FFFFFF” background_enable_color=”on” global_colors_info=”{}” follow_button=”off” url_new_window=”on”]LinkedIn[\/et_pb_social_media_follow_network][\/et_pb_social_media_follow][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_5,1_5,1_5,1_5,1_5″ _builder_version=”4.18.1″ _module_preset=”default” custom_margin=”|auto|6px|auto||” custom_padding=”22px||6px|||” global_colors_info=”{}”][et_pb_column type=”1_5″ _builder_version=”4.18.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.18.1″ _module_preset=”default” text_font=”Lato||||||||” text_text_color=”#FFFFFF” text_font_size=”16px” global_colors_info=”{}”]

Amsterdam<\/strong><\/span>
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411<\/p>\n

 <\/p>[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.18.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.18.1″ _module_preset=”default” text_font=”Lato||||||||” text_text_color=”#FFFFFF” text_font_size=”16px” global_colors_info=”{}”]

D\u00fcsseldorf<\/strong><\/span>
K\u00f6nigsallee 42
40212 D\u00fcsseldorf
+49 (0) 211 96290120<\/p>[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.18.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.18.1″ _module_preset=”default” text_font=”Lato||||||||” text_text_color=”#FFFFFF” text_font_size=”16px” global_colors_info=”{}”]

Contact<\/strong><\/span>
info@hollandcapital.nl<\/p>[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.18.1″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][et_pb_column type=”1_5″ _builder_version=”4.18.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.18.1″ _module_preset=”default” text_font=”Lato||||||||solid” text_text_color=”#FFFFFF” text_font_size=”16px” link_text_color=”#FFFFFF” custom_margin=”1px||||false|false” global_colors_info=”{}” link_text_color__hover_enabled=”on|desktop” link_text_color__hover=”#B68013″]

\n

Privacy statement<\/span><\/a><\/p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]\n","protected":false},"excerpt":{"rendered":"

Since 2019, Defibrion’s management team has successfully collaborated with Holland Capital. The shares of Defibrion are being sold to IK and the company\u2019s management team. <\/p>\n","protected":false},"author":4,"featured_media":987505309,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"2880","footnotes":"","_links_to":"","_links_to_target":""},"categories":[97],"tags":[108,109,110,116,132],"class_list":["post-987505307","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-engels","tag-healthcare","tag-private-equity","tag-investeren","tag-overname","tag-investment-nieuws"],"yoast_head":"\nHolland Capital Announces Successful Exit of Defibrion to IK Partners - Holland Capital<\/title>\n<meta name=\"description\" content=\"Since 2019, Defibrion's management team has successfully collaborated with Holland Capital. The shares of Defibrion are being sold to IK and the company\u2019s management team. IK is a leading European private equity firm focused on investments in the Benelux, DACH, France, Nordics and the UK.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hollandcapital.nl\/en\/holland-capital-announces-successful-exit-of-defibrion-to-ik-partners\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Holland Capital Announces Successful Exit of Defibrion to IK Partners\" \/>\n<meta property=\"og:description\" content=\"Since 2019, Defibrion's management team has successfully collaborated with Holland Capital. The shares of Defibrion are being sold to IK and the company\u2019s management team. IK is a leading European private equity firm focused on investments in the Benelux, DACH, France, Nordics and the UK.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/hollandcapital.nl\/en\/holland-capital-announces-successful-exit-of-defibrion-to-ik-partners\/\" \/>\n<meta property=\"og:site_name\" content=\"Holland Capital\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.linkedin.com\/company\/hollandcapital\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-07-23T07:36:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-23T07:45:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/hollandcapital.nl\/wp-content\/uploads\/2024\/07\/Postzegel-logos-4-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"320\" \/>\n\t<meta property=\"og:image:height\" content=\"200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Grytsje\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Grytsje\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/holland-capital-announces-successful-exit-of-defibrion-to-ik-partners\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/holland-capital-announces-successful-exit-of-defibrion-to-ik-partners\\\/\"},\"author\":{\"name\":\"Grytsje\",\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/#\\\/schema\\\/person\\\/47531bfba3e92fb43b39366649af58c9\"},\"headline\":\"Holland Capital Announces Successful Exit of Defibrion to IK Partners\",\"datePublished\":\"2024-07-23T07:36:05+00:00\",\"dateModified\":\"2024-07-23T07:45:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/holland-capital-announces-successful-exit-of-defibrion-to-ik-partners\\\/\"},\"wordCount\":1429,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/holland-capital-announces-successful-exit-of-defibrion-to-ik-partners\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/hollandcapital.nl\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/Postzegel-logos-4-1.png\",\"keywords\":[\"Healthcare\",\"Private equity\",\"investeren\",\"Overname\",\"investment nieuws\"],\"articleSection\":[\"News Engels\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/holland-capital-announces-successful-exit-of-defibrion-to-ik-partners\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/holland-capital-announces-successful-exit-of-defibrion-to-ik-partners\\\/\",\"url\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/holland-capital-announces-successful-exit-of-defibrion-to-ik-partners\\\/\",\"name\":\"Holland Capital Announces Successful Exit of Defibrion to IK Partners - Holland Capital\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/holland-capital-announces-successful-exit-of-defibrion-to-ik-partners\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/holland-capital-announces-successful-exit-of-defibrion-to-ik-partners\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/hollandcapital.nl\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/Postzegel-logos-4-1.png\",\"datePublished\":\"2024-07-23T07:36:05+00:00\",\"dateModified\":\"2024-07-23T07:45:58+00:00\",\"description\":\"Since 2019, Defibrion's management team has successfully collaborated with Holland Capital. The shares of Defibrion are being sold to IK and the company\u2019s management team. IK is a leading European private equity firm focused on investments in the Benelux, DACH, France, Nordics and the UK.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/holland-capital-announces-successful-exit-of-defibrion-to-ik-partners\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/holland-capital-announces-successful-exit-of-defibrion-to-ik-partners\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/holland-capital-announces-successful-exit-of-defibrion-to-ik-partners\\\/#primaryimage\",\"url\":\"https:\\\/\\\/hollandcapital.nl\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/Postzegel-logos-4-1.png\",\"contentUrl\":\"https:\\\/\\\/hollandcapital.nl\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/Postzegel-logos-4-1.png\",\"width\":320,\"height\":200},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/holland-capital-announces-successful-exit-of-defibrion-to-ik-partners\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Holland Capital Announces Successful Exit of Defibrion to IK Partners\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/#website\",\"url\":\"https:\\\/\\\/hollandcapital.nl\\\/\",\"name\":\"Holland Capital\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/hollandcapital.nl\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/#organization\",\"name\":\"Holland Capital Management BV\",\"url\":\"https:\\\/\\\/hollandcapital.nl\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/hollandcapital.nl\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/HC_logo_handtekening.png\",\"contentUrl\":\"https:\\\/\\\/hollandcapital.nl\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/HC_logo_handtekening.png\",\"width\":186,\"height\":65,\"caption\":\"Holland Capital Management BV\"},\"image\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/hollandcapital\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/#\\\/schema\\\/person\\\/47531bfba3e92fb43b39366649af58c9\",\"name\":\"Grytsje\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/287ef07ad6e09cb3368ae7d01a80dfd73cb7a9bb6d5a8f35a2dd4f0c09b95f9a?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/287ef07ad6e09cb3368ae7d01a80dfd73cb7a9bb6d5a8f35a2dd4f0c09b95f9a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/287ef07ad6e09cb3368ae7d01a80dfd73cb7a9bb6d5a8f35a2dd4f0c09b95f9a?s=96&d=mm&r=g\",\"caption\":\"Grytsje\"},\"url\":\"https:\\\/\\\/hollandcapital.nl\\\/en\\\/author\\\/grytsje\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Holland Capital Announces Successful Exit of Defibrion to IK Partners - Holland Capital","description":"Since 2019, Defibrion's management team has successfully collaborated with Holland Capital. The shares of Defibrion are being sold to IK and the company\u2019s management team. IK is a leading European private equity firm focused on investments in the Benelux, DACH, France, Nordics and the UK.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hollandcapital.nl\/en\/holland-capital-announces-successful-exit-of-defibrion-to-ik-partners\/","og_locale":"en_US","og_type":"article","og_title":"Holland Capital Announces Successful Exit of Defibrion to IK Partners","og_description":"Since 2019, Defibrion's management team has successfully collaborated with Holland Capital. The shares of Defibrion are being sold to IK and the company\u2019s management team. IK is a leading European private equity firm focused on investments in the Benelux, DACH, France, Nordics and the UK.","og_url":"https:\/\/hollandcapital.nl\/en\/holland-capital-announces-successful-exit-of-defibrion-to-ik-partners\/","og_site_name":"Holland Capital","article_publisher":"https:\/\/www.linkedin.com\/company\/hollandcapital\/","article_published_time":"2024-07-23T07:36:05+00:00","article_modified_time":"2024-07-23T07:45:58+00:00","og_image":[{"width":320,"height":200,"url":"https:\/\/hollandcapital.nl\/wp-content\/uploads\/2024\/07\/Postzegel-logos-4-1.png","type":"image\/png"}],"author":"Grytsje","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Grytsje","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/hollandcapital.nl\/en\/holland-capital-announces-successful-exit-of-defibrion-to-ik-partners\/#article","isPartOf":{"@id":"https:\/\/hollandcapital.nl\/en\/holland-capital-announces-successful-exit-of-defibrion-to-ik-partners\/"},"author":{"name":"Grytsje","@id":"https:\/\/hollandcapital.nl\/#\/schema\/person\/47531bfba3e92fb43b39366649af58c9"},"headline":"Holland Capital Announces Successful Exit of Defibrion to IK Partners","datePublished":"2024-07-23T07:36:05+00:00","dateModified":"2024-07-23T07:45:58+00:00","mainEntityOfPage":{"@id":"https:\/\/hollandcapital.nl\/en\/holland-capital-announces-successful-exit-of-defibrion-to-ik-partners\/"},"wordCount":1429,"commentCount":0,"publisher":{"@id":"https:\/\/hollandcapital.nl\/#organization"},"image":{"@id":"https:\/\/hollandcapital.nl\/en\/holland-capital-announces-successful-exit-of-defibrion-to-ik-partners\/#primaryimage"},"thumbnailUrl":"https:\/\/hollandcapital.nl\/wp-content\/uploads\/2024\/07\/Postzegel-logos-4-1.png","keywords":["Healthcare","Private equity","investeren","Overname","investment nieuws"],"articleSection":["News Engels"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/hollandcapital.nl\/en\/holland-capital-announces-successful-exit-of-defibrion-to-ik-partners\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/hollandcapital.nl\/en\/holland-capital-announces-successful-exit-of-defibrion-to-ik-partners\/","url":"https:\/\/hollandcapital.nl\/en\/holland-capital-announces-successful-exit-of-defibrion-to-ik-partners\/","name":"Holland Capital Announces Successful Exit of Defibrion to IK Partners - Holland Capital","isPartOf":{"@id":"https:\/\/hollandcapital.nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/hollandcapital.nl\/en\/holland-capital-announces-successful-exit-of-defibrion-to-ik-partners\/#primaryimage"},"image":{"@id":"https:\/\/hollandcapital.nl\/en\/holland-capital-announces-successful-exit-of-defibrion-to-ik-partners\/#primaryimage"},"thumbnailUrl":"https:\/\/hollandcapital.nl\/wp-content\/uploads\/2024\/07\/Postzegel-logos-4-1.png","datePublished":"2024-07-23T07:36:05+00:00","dateModified":"2024-07-23T07:45:58+00:00","description":"Since 2019, Defibrion's management team has successfully collaborated with Holland Capital. The shares of Defibrion are being sold to IK and the company\u2019s management team. IK is a leading European private equity firm focused on investments in the Benelux, DACH, France, Nordics and the UK.","breadcrumb":{"@id":"https:\/\/hollandcapital.nl\/en\/holland-capital-announces-successful-exit-of-defibrion-to-ik-partners\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hollandcapital.nl\/en\/holland-capital-announces-successful-exit-of-defibrion-to-ik-partners\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/hollandcapital.nl\/en\/holland-capital-announces-successful-exit-of-defibrion-to-ik-partners\/#primaryimage","url":"https:\/\/hollandcapital.nl\/wp-content\/uploads\/2024\/07\/Postzegel-logos-4-1.png","contentUrl":"https:\/\/hollandcapital.nl\/wp-content\/uploads\/2024\/07\/Postzegel-logos-4-1.png","width":320,"height":200},{"@type":"BreadcrumbList","@id":"https:\/\/hollandcapital.nl\/en\/holland-capital-announces-successful-exit-of-defibrion-to-ik-partners\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/hollandcapital.nl\/en\/"},{"@type":"ListItem","position":2,"name":"Holland Capital Announces Successful Exit of Defibrion to IK Partners"}]},{"@type":"WebSite","@id":"https:\/\/hollandcapital.nl\/#website","url":"https:\/\/hollandcapital.nl\/","name":"Holland Capital","description":"","publisher":{"@id":"https:\/\/hollandcapital.nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hollandcapital.nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/hollandcapital.nl\/#organization","name":"Holland Capital Management BV","url":"https:\/\/hollandcapital.nl\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/hollandcapital.nl\/#\/schema\/logo\/image\/","url":"https:\/\/hollandcapital.nl\/wp-content\/uploads\/2023\/06\/HC_logo_handtekening.png","contentUrl":"https:\/\/hollandcapital.nl\/wp-content\/uploads\/2023\/06\/HC_logo_handtekening.png","width":186,"height":65,"caption":"Holland Capital Management BV"},"image":{"@id":"https:\/\/hollandcapital.nl\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/hollandcapital\/"]},{"@type":"Person","@id":"https:\/\/hollandcapital.nl\/#\/schema\/person\/47531bfba3e92fb43b39366649af58c9","name":"Grytsje","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/287ef07ad6e09cb3368ae7d01a80dfd73cb7a9bb6d5a8f35a2dd4f0c09b95f9a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/287ef07ad6e09cb3368ae7d01a80dfd73cb7a9bb6d5a8f35a2dd4f0c09b95f9a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/287ef07ad6e09cb3368ae7d01a80dfd73cb7a9bb6d5a8f35a2dd4f0c09b95f9a?s=96&d=mm&r=g","caption":"Grytsje"},"url":"https:\/\/hollandcapital.nl\/en\/author\/grytsje\/"}]}},"_links":{"self":[{"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/posts\/987505307","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/comments?post=987505307"}],"version-history":[{"count":3,"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/posts\/987505307\/revisions"}],"predecessor-version":[{"id":987505317,"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/posts\/987505307\/revisions\/987505317"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/media\/987505309"}],"wp:attachment":[{"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/media?parent=987505307"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/categories?post=987505307"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hollandcapital.nl\/en\/wp-json\/wp\/v2\/tags?post=987505307"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}